SCHEMBL21993435

SCHEMBL21993435

Cc1cc(-c2ccc(C3C(C#N)=C(N)Oc4c3c(=O)oc3ccccc43)cc2)cnc1Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.62
KDM4E B2RXH2 10/20 0.62
KMT2A Q03164 7/20 0.62
MEN1 O00255 6/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
TOP2A P11388 4/20 0.61
TSHR P16473 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
ALDH1A1 P00352 4/20 0.59
HTT P42858 3/20 0.55
NPSR1 Q6W5P4 2/20 0.55
XDH P47989 1/20 0.54
LMNA P02545 4/20 0.54
GAA P10253 2/20 0.51
HPGD P15428 2/20 0.51
GLA P06280 1/20 0.51
ATM Q13315 1/20 0.51
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911748 0.91 MAPT (0.65) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21992933 0.91 KDM4E (0.50) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21932709 0.90 MAPT (0.62) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL30233363 0.90 MAPT (0.62) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21993046 0.89 KDM4E (0.54) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21993015 0.88 TOP2A (0.54) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21993436 0.87 MAPT (0.68) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21992955 0.85 MAPT (0.72) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21992940 0.83 MAPT (0.77) MAPTKDM4EKMT2AMEN1CYP1A2
SCHEMBL21992984 0.82 MAPT (0.74) MAPTKDM4EKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2021-10-12 US disclosed
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 ETF1, F3, DNASE1L3 MAPT 4590/4885KDM4E 3966/4885KMT2A 4155/4885
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 ETF1, F3, DNASE1L3 MAPT 4590/4885KDM4E 3966/4885KMT2A 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.